Domestic Substitution Accelerates: Local Manufacturers Break Through in The High-end Market Of Ultrasound Imaging Needles

Domestic substitution accelerates: Local manufacturers break through in the high-end market of ultrasound imaging needles
For a long time, the global ultrasonic imaging needle market has been monopolized by international giants such as Wilson-Cook Medical and Spectra Medical Devices. These companies have dominated the high-end market by leveraging their technological, brand, and clinical advantages. With the rapid rise of China's interventional medical device technology, local high-quality manufacturers like Mekon and ZorayPT have focused on technological breakthroughs, cost optimization, and clinical services, accelerating the domestic substitution of ultrasonic imaging needles and breaking the international monopoly, promoting the domestic autonomy and controllability of high-end interventional consumables.
The core technical barriers of ultrasonic imaging needles are concentrated in three areas: ultrasonic imaging coating, precise processing technology, and material compatibility. In the past, international manufacturers, relying on years of technological accumulation, mastered the core formulas and processing techniques. Domestic manufacturers have long been in the mid-to-low-end market. In recent years, local manufacturers have increased their research and development investment, established professional technical R&D teams, and overcome technical challenges such as high-molecular imaging coating, high-precision needle rod processing, and uniform coating adhesion, achieving product performance on par with international brands and even surpassing some indicators.
The technological breakthroughs of local manufacturers are primarily reflected in the core imaging technology. Mekon independently developed the polymer microbubble coating technology, which abandons the traditional backward processes and significantly improves the ultrasonic imaging effect. The clarity of the needle shaft and needle tip in the ultrasonic image is comparable to that of imported brands. At the same time, the coating adhesion is optimized to solve the problems of easy detachment of domestic needle coatings and uneven imaging. The imaging during the puncture process is stable, meeting the precise operation requirements of clinical practice. ZorayPT has upgraded through precise processing technology, with the size accuracy of the needle body controlled within ±0.01mm, and the sharpness of the needle tip and the smoothness of the needle body have been significantly improved. The puncture process causes less damage to soft tissues, and the postoperative discomfort of patients is lower.
The cost-performance advantage is the core competitiveness that enables domestic ultrasonic imaging needles to stand out. Local manufacturers, leveraging the complete domestic industrial chain advantages, optimize the production process, reduce production costs, and eliminate intermediate expenses such as import tariffs, logistics, and agency fees. As a result, their product pricing is much lower than that of similar imported devices, significantly reducing the procurement costs for hospitals and treatment costs for patients. They possess strong competitiveness in the grassroots medical institutions and private hospital markets. At the same time, by virtue of their high cost-performance ratio, they quickly enter the tertiary hospital market and gradually penetrate the high-end market.
The localization of clinical services is a unique advantage of domestic manufacturers. Compared with international brands, domestic manufacturers have a better understanding of domestic clinical surgical habits, doctors' operational needs, and patient physical characteristics. They can quickly respond to clinical feedback, optimize product design, and customize specific specifications. At the same time, they establish local clinical service teams to provide on-site operation training, in-hospital technical guidance, and rapid response after-sales services, addressing the issues of delayed service and inadequate technical support of imported brands, and enhancing doctors' usage experience and clinical recognition.
Policy support has injected strong impetus into the domestic substitution. The national medical device innovation review and approval policies, centralized procurement policies for medical consumables, and support policies for domestic medical equipment have continuously favored domestic high-end medical consumables, encouraging hospitals to prioritize the purchase of domestic equipment, providing a broad market space for domestic ultrasonic imaging needle manufacturers. Under the promotion of the centralized procurement policy, domestic high-quality ultrasonic imaging needles, with their cost-performance and compliance advantages, successfully won bids for various regional centralized procurement projects, and their market share has continued to increase, gradually replacing imported products as the mainstream choice in clinical settings.
At present, domestic ultrasonic imaging needles have been widely used in clinical settings such as nerve block, tissue biopsy, medical aesthetic injections, and fluid drainage on a large scale. The product quality and clinical effects have been widely recognized. The local manufacturers have not stopped at their current achievements. They continue to increase research and development investment, upgrading towards intelligence, refinement, and customization. They are developing integrated ultrasonic imaging puncture devices and degradable ultrasonic imaging needles, among other high-end products, to further narrow the technological gap with international giants.
From following the technology to achieving independent innovation, from filling the low-end market gap to breaking through in the high-end market, local manufacturers of ultrasonic imaging needles have achieved a leapfrog development. In the future, with continuous upgrades in research and development technology, continuous improvement of clinical services, and gradual enhancement of brand influence, domestic ultrasonic imaging needles will fully replace products from foreign markets in the high-end market. They will not only meet the domestic clinical needs, but also go abroad to participate in global market competition, build a Chinese brand of interventional medical consumables, and promote China from a medical device manufacturing country to a medical device manufacturing power.